On the HCPLive Internal Medicine condition center page, resources on the topics of medical news and expert insight into internal medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on internal medicine research, treatment, and drug development.
May 10th 2024
These data suggest that a multidisciplinary clinic approach results in several benefits including reduced risk of cardiovascular events among those with psoriasis.
Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Endocrine Month in Review: September 2022
September 25th 2022Our endocrinology month in review spotlights the most popular content from the past month. Our top content from September 2022 includes new guideline recommendations from the ADA/EASD, new data on semaglutide 2.4 mg and tirzepatide, a label update for finerenone, & more!
High HbA1c Linked to Increased Risk of Trigger Finger in Both Type 1 & Type 2 Diabetes
September 6th 2022An analysis of national register data from Sweden suggests elevated HbA1c levels were linked to an increase in the likelihood of developing stenosing tenosynovitis, more commonly known as trigger finger, among people with either type 1 or type 2 diabetes.
GSA Releases New Toolkit for Obesity Management in Older Adults
August 18th 2022On August 16, the Gerontological Society of America released a 63-page provider toolkit aimed at providing clinicians managing older patients with obesity with necessary tools and resources to improve the recognition and treatment of obesity in this patient population.
Greater Guselkumab Response More Likely Among Younger, Less Obese Psoriasis Patients
A post-hoc analysis of clinical trial data found that psoriasis patients who were younger, less obese and had less severe psoriasis were more likely to achieve super-response to biologic treatment with guselkumab.
Biologic Agents May Reduce Risk of Mental Health Disorders in Some Patients with Psoriasis
Biologic agents may reduce the risk of mental health disorders among patients with moderate-to-severe psoriasis who discontinued treatment with conventional systemic agents, researchers in Canada found.
Phase 2 Data Support Continued Evaluation of Mitapivat for Alpha, Beta Thalassemia
August 16th 2022Data from this phase 2 study revealed that the efficacy and safety results support the continued investigation of mitapivat as treatment for adults with either α- or β-thalassemia who are not dependent on transfusions.
Artificial Intelligence Tools Could Use ECGs to Predict Type 2, Prediabetes
August 10th 2022Called the DiaBeats algorithm, new research suggests leveraging the machine learning-based algorithm, combined with ECG recordings, could help predict increased risk of developing prediabetes and type 2 diabetes.
GnRH Agonists for Prostate Cancer Could Increase CVD Risk in Type 2 Diabetes
August 9th 2022New research suggests there was a 53% greater 5-year risk of cardiovascular disease in men with type 2 diabetes who received a GnRH agonist for prostate cancer compared with their counterparts who did not receive GnRH agonists.
Trial Suggests Time-Restricted Eating Could Aid in Weight Loss, Improve Blood Pressure
August 8th 2022Data from a 14-week randomized clinical trial suggests adherence to a time-restricted diet was associated with significant differences in weight loss and improvements in blood pressure compared to a typical diet.